- Report
- April 2023
- 147 Pages
Global
From €4516EUR$4,949USD£3,837GBP
- Report
- May 2024
- 140 Pages
Global
From €4516EUR$4,949USD£3,837GBP
- Report
- March 2024
- 200 Pages
Global
From €3787EUR$4,150USD£3,218GBP
- Report
- March 2024
- 200 Pages
Global
From €3787EUR$4,150USD£3,218GBP
- Report
- January 2024
- 200 Pages
Global
From €3787EUR$4,150USD£3,218GBP
- Report
- January 2024
- 200 Pages
Global
From €3787EUR$4,150USD£3,218GBP
- Report
- May 2024
- 298 Pages
Global
From €7254EUR$7,950USD£6,164GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1141EUR$1,250USD£969GBP
- Report
- March 2024
- 174 Pages
Global
From €6844EUR$7,500USD£5,815GBP
- Report
- February 2024
- 200 Pages
Global
From €6844EUR$7,500USD£5,815GBP
- Report
- May 2023
- 220 Pages
Global
From €2281EUR$2,500USD£1,938GBP
- Report
- May 2023
- 450 Pages
Global
From €4563EUR$5,000USD£3,877GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2966EUR$3,250USD£2,520GBP
- Report
- April 2020
- 80 Pages
Global
From €3604EUR$3,950USD£3,063GBP
- Report
- September 2023
- 138 Pages
Global
From €4061EUR$4,450USD£3,450GBP
- Report
- May 2023
- 450 Pages
Global
From €4563EUR$5,000USD£3,877GBP
- Report
- January 2022
- 60 Pages
Global
From €3604EUR$3,950USD£3,063GBP
- Report
- November 2023
- 209 Pages
Global
From €4061EUR$4,450USD£3,450GBP
- Report
- November 2023
- 77 Pages
France
From €3194EUR$3,500USD£2,714GBP
- Report
- January 2024
- 201 Pages
Global
From €4106EUR$4,500USD£3,489GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more